Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Kim E de Roode

3PUBLICATIONS

19CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Supramolecular chemistryMolecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Sep 27, 2025

Click-to-Release for Controlled Immune Cell Activation: Tumor-Targeted Unmasking of an IL12 Prodrug.

Martijn H den Brok, Kim E de Roode, Luc H M Zijlmans

|Apr 09, 2025

Site-directed multivalent conjugation of antibodies to ubiquitinated payloads.

Angela F El Hebieshy, Zacharias Wijfjes, Camille M Le Gall

|Feb 24, 2024

Towards the Magic Radioactive Bullet: Improving Targeted Radionuclide Therapy by Reducing the Renal Retention of Radioligands.

Kim E de Roode, Lieke Joosten, Martin Behe

Pageof 1

Frequent Collaborators

1 joint publications

Lieke Joosten

1 joint publications

Martin Behe

1 joint publications

Angela F El Hebieshy

1 joint publications

Zacharias Wijfjes

1 joint publications

Camille M Le Gall

1 joint publications

Jim Middelburg

1 joint publications

Douwe J Dijkstra

1 joint publications

Floris J van Dalen

1 joint publications

Bjorn R van Doodewaerd

1 joint publications

Carl G Figdor

Frequent Collaborators

1 joint publications

Lieke Joosten

1 joint publications

Martin Behe

1 joint publications

Angela F El Hebieshy

1 joint publications

Zacharias Wijfjes

Top Related Videos

Tractable <em>In Vivo</em> Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Tractable <em>In Vivo</em> Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on : Aug 01, 2025

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on : Sep 14, 2018

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on : Apr 24, 2020

See more related videos

Top Related Videos

Tractable <em>In Vivo</em> Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Tractable <em>In Vivo</em> Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on : Aug 01, 2025

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on : Sep 14, 2018

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

Published on : Apr 24, 2020

See more related videos